Stijn van Rompay

Founder at HYLORIS PHARMACEUTICALS SA

Net worth: 43 M $ as of 2026-07-30

50 year

33 connections

Health Technology

Consumer Services

Electronic Technology

Profile

Stijn van Rompay was the founder of Uteron Pharma SA, founded in 2010, where the title held was General Manager from 2010 to 2015.
Mr. van Rompay is the founder of Hyloris Pharmaceuticals SA, founded in 2012, holding the title Chief Executive Officer & Executive Director starting in 2025.
Mr. van Rompay is also the founder of Alter Pharma Group NV.
Current jobs include Director at ImCyse SA since 2012, Managing Director & Director at EXO Biologics SA since 2019, and Managing Director & Director at Hyloris Developments SA since 2020.
Former jobs include Non-Executive Director at Coalesce Product Development Ltd. and Chief Financial Officer at Docpharma NV.
Education includes graduate degree from the University of Antwerp.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
HYLORIS PHARMACEUTICALS SA 27.65%	2026-03-30	7,743,067 ( 27.65% )	43 M $	2026-07-30

Stijn van Rompay active positions

Companies	Position	Start
HYLORIS PHARMACEUTICALS SA	Founder	2011-12-31
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Director/Board Member	2011-12-31
EXO Biologics SA EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company	Director/Board Member	2019-08-28
Hyloris Developments SA Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Chief Executive Officer	2020-04-19

All active positions of Stijn van Rompay

Former positions of Stijn van Rompay

Companies	Position	End
Coalesce Product Development Ltd. Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices	Director/Board Member	2024-09-26
Uteron Pharma SA Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices	Chief Executive Officer	2015-07-31
Alter Pharma Group NV Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Founder	-
Docpharma NV Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs	Chief Executive Officer	-

See the detail of Stijn van Rompay's experience

Training of Stijn van Rompay

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stijn van Rompay's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Docpharma NV Docpharma NV Pharmaceuticals: MajorHealth Technology Provides generic drugs	Health Technology
University of Antwerp University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Uteron Pharma SA Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices	Electronic Technology
ImCyse SA ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies	Health Technology
Alter Pharma Group NV Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Hyloris Pharmaceuticals SA Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs	Health Technology
EXO Biologics SA EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
Coalesce Product Development Ltd. Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Develops inhalation devices	Health Technology
Hyloris Developments SA Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Health Technology